Artykuły - Zaburzenia funkcji poznawczych w stwardnieniu rozsianym
 
 
Zaloguj się...
Nazwa użytkownika:

Hasło użytkownika:

Zapamiętaj mnie



Zapomniałem hasła

Zarejestruj się!
Menu
Stowarzyszenie
Strona główna
Artykuły
Galeria
Forum
Download
Linki
 
Zaburzenia funkcji poznawczych w stwardnieniu rozsianym
  Napisany Fri 18 Jan 2008 przez Cypek (11980 odsłon)

Piśmiennictwo

1. O’Connor P. Canadian Multiple Sclerosis Working Group. Key issues in the diagnosis and treatment of multiple sclerosis. Neurology 2002; 59: 1-33.
2. Cendrowski W. Stwardnienie rozsiane. PZWL, Warszawa 1993.
3. Mirowska D., Członkowska A. Uszkodzenie aksonów w patogenezie stwardnienia rozsianego. Neurol Neurochir Pol 2002; 36: 777-789.
4. Basso M.R., Beason-Hazen S., Lynn J. i wsp. Screening for cognitive dysfunction in multiple sclerosis. Arch Neurol 1996; 53: 980-984.
5. Amato M.P., Zipoli V. Clinical management of cognitive impairment in multiple sclerosis: a review of current evidence. Int MSJ 2003; 10: 72-83.
6. Feinstein A. Neuropsychological dysfunction in multiple sclerosis. MS Journal 1995; 2: 61-67.
7. Rao S.M., Leo G.J., Bernardin L. i wsp. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns and prediction. Neurology 1991; 41: 685-691.
8. Ron M.A., Callanan M. Cognitive abnormalities in MS: a psychometric and MRI study. Psychol Med 1991; 21: 59-68.
9. Thornton A.E., Raz N. Memory impairment in multiple sclerosis: a quantitative review. Neuropsychology 1997; 3: 357-366.
10. De Luca J., Barbieri-Berger S., Johnson S.K. The nature of memory impairment in multiple sclerosis: acquisition versus retrieval. J Clin Exp Neuropsychol 1994; 16: 183-185.
11. Szepietowska E.M. Zaburzenia w funkcjonowaniu poznawczym chorych na stwardnienie rozsiane. W: Herzyk A., Kądzielawa D. [red.]. Związek mózg-zachowanie w ujęciu neuropsychologii klinicznej. Wyd. UMCS, Lublin 1997.
12. Beatty W., Monson M. Metamemory in MS. J Clin Exp Neuropsychol 1991; 13: 309-327.
13. Jennekens-Schinkel A., Lanser J., van der Valde E.A. i wsp. Neuropsychological assessment in patients with multiple sclerosis and mild functional impairment. J Neurol Neurosurg Psychiatry 1991; 54: 757-762.
14. Honig L.S., Ramsay R.E., Sheremata W.A. Event-related potential P-300 in multiple sclerosis. Relation to magnetic resonance imaging and cognitive impairment. Arch Neurol 1992; 49: 44-50.
15. Plohmann A.M., Kappos L., Ammann W. Computer assisted retraining of attentional impairment in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 1998; 64: 455-462.
16. Lyon-Caen O., Jouvent R., Hauser S. i wsp. Cognitive function in recent-onset demyelinating disease. Arch Neurol 1986;
43: 1138-1141.
17. Arnett P.A., Rao S.M., Bernardin L. i wsp. Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis. Neurology 1994; 44: 420-425.
18. Foong J., Rozewicz I., Quaghebeur G. i wsp. Executive function in multiple sclerosis. The role of frontal lobe pathology. Brain 1997; 120: 15-26.
19. Rao S.M., Hommke T.A., Speech T.J., Wisconsin Card Sorting Test performance in relapsing-remitting and chronic progressive multiple sclerosis. J Consult Clin Psychol 1987; 55: 263-265.
20. Huijbregts S.C., Kalkers N.F., de Sonneville L.M. i wsp. Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS. Neurology 2004; 27: 335-339.
21. Marsh G. Disability and intellectual function in multiple sclerosis patients. J Nerv Ment Dis 1980; 168: 758-762.
22. Rudick R., Antel J., Confavreux C. i wsp. Clinical outcomes assessment in multiple sclerosis. Ann Neurol 1996; 40: 469-479.
23. Vickrey B., Hays R., Harooni R. i wsp. A health-related quality of life measure for multiple sclerosis. Qual Life Research 1995; 4: 187-206.
24. Ware J., Sherbourne C. The MOS 36-item short form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
25. Cutajar R., Ferriani E., Scandellari C. i wsp. Cognitive function and quality of life in multiple sclerosis patients. J Neurovirol 2000; 6: 186-190.
26. Sailer M., Heinze H.J., Schoenfeld M.A. i wsp. Amantadine influences cognitive processing in patients with multiple sclerosis. Pharmacopsychiatry 2000; 33: 28-37.
27. Oliveri R.L., Sibilia G., Valentino P. i wsp. Pulsed methylprednisolone induces a reversible impairment of memory in patients with relapsing-remitting multiple sclerosis. Acta Neurol Scand 1998; 97: 366-369.
28. Pliskin N.H., Hamer D.P., Goldstein D.S. i wsp. Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b. Neurology 1996; 47: 1463-1468.
29. Barak Y., Achiron A. Effect of interferon-beta-1b on cognitive functions in multiple sclerosis. Eur Neurol 2002; 47: 11-14.
30. Fischer J.S., Priore R.L., Jacobs L.D. i wsp. Neuropsychological effects of interferon beta 1-a in relapsing multiple sclerosis. Ann Neurol 2000; 48: 885-892.
31. Weinstein A., Schwid S.I., Schiffer R.B. i wsp. Neuropsychologic status in multiple sclerosis after treatment with glatiramer. Arch Neurol 1999; 56: 319-324.
32. Krupp L.B., Christodoulou C., Melville P. i wsp. Donepezil improved memory in multiple sclerosis in a randomized clinical trial. Neurology 2004; 63: 1579-1585.
33. Ruggieri R.M., Palermo R., Vitello G. i wsp. Cognitive impairment in patients suffering from relapsing-remitting multiple sclerosis with EDSS
34. Feinstein A., Ron M., Thompson A. A serial study of psychometric and magnetic resonance imaging changes in multiple sclerosis. Brain 1993; 116: 569-602.
35. Kujala P., Portin R., Ruutiainen J. The progress of cognitive decline in multiple sclerosis. A controlled 3-years follow-up. Brain 1997; 120: 289-297.
36. Amato M.P., Ponziani G., Siracusa G. i wsp. Cognitive dysfunction in early-onset multiple sclerosis; a reappraisal after 10 years. Arch Neurol 2001; 58: 1602-1606.
37. Pozzilli C., Passafiume D., Bemardi S. Anatomical and functional correlate of cognitive deficit in multiple sclerosis. J Neurol Sci 1993; 115 (Suppl.): 55-58.
38. Hohol M.J., Guttman C.R., Orav J. Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple scerosis. Arch Neurol 1997; 54: 1018-1025.
39. Foong J., Rozewicz L., Quanghebeur G. i wsp. Neuropsychological deficits in multiple sclerosis after acute relapse. J Neurol Neurosurg Psychiatry 1998; 64: 529-532.
40. Swirsky-Sacchetti T., Mitchell D., Seward J. i wsp. Neuropsychological and structural brain lesions in multiple sclerosis: A regional analysis. Neurology 1992; 42: 1291-1295.
41. Modestowicz R., Sosnowski P., Wender M. i wsp. Morfologia ognisk demielinizacyjnych a zaburzenia funkcji poznawczych i emocjonalnych u chorych na stwardnienie rozsiane. Neurol Neurochir Pol 2000; 34: 23-33.
42. Filippi M., Tortorella C., Rovaris M. i wsp. Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis. J Neurol Neurosurg Psychiatry 2000; 68: 157-161.
43. Rovaris M., Filippi M. MRI correlates of cognitive dysfunction in multiple sclerosis patients. J Neurovirol 2000; 6: 172-175.
44. Rovaris M., Filippi M., Falautano M. i wsp. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 1998; 50: 1601-1608.
45. Benedict R.H., Carone D.A., Bakshi R. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis. J Neuroimaging 2004; 14 (3 Suppl.): 36-45.
46. Zivadinov R., De Masi R., Nasueli D. i wsp. MRI techniques and cognitive impairment in the early phase of relapsing-remitting multiple sclerosis. Neuroradiology 2001; 43: 272-278.
47. Benedict R., Weinstock-Guttman B., Fishman I. i wsp. Prediction of neuropsychological impairment in multiple sclerosis. Comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 2004; 61: 226-230.
48. Dalton C.M., Chard D.T., Davies G.R. i wsp. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004; 127: 1101-1107.
49. Amato M.P., Bartolozzi M.L., Zipoli V. i wsp. Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology 2004; 13: 89-93.
50. Staffen W., Mair A., Zauner H. i wsp. Cognitive function and fMRI in patients with multiple sclerosis: evidence for compesatory cortical activation during an attention task. Brain 2002; 125: 1275-1282.
51. Wishart H.A. Saykin A.J., McDonald B.C. i wsp. Brain activation patterns associated with working memory in relapsing-remitting MS. Neurology 2004; 62: 234-238.
52. Rao S.M., Bernardin L., Leo G. Cerebral disconnection in multiple sclerosis: relationship to atrophy of the Corpus Callosum. Arch Neurol 1989; 46: 918-920.
53. Bakshi R., Benedict R.H, Bermel R.A. i wsp. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol 2002; 59: 62-68.
54. Blinkenberg M., Rune K., Jensen C.V. i wsp. Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS. Neurology 2000; 54: 558-564.
55. Filley C.M. The behavioral neurology of cerebral white matter. Neurology 1998; 50: 1535-1540.
strona 2 z 2 poprzedni :: następny
Powrót :: Drukuj :: E-mail
 
Komentarze są własnością ich autorów. Nie ponosimy odpowiedzialności za ich treść.
Szukaj
Najnowsze artykuły
Najpopularniejsze artykuły
Kto jest online?
2 użytkowników jest na stronie (1 użytkowników przegląda Artykuły )

Użytkownicy: 0
Goście: 2

więcej...
Licznik

Copyright © by Biegusy 2006-2010
Stowarzyszenie Chorych na Stwardnienie Rozsiane SM w Zielonej Górze
Stwardnienie Rozsiane | Antymail | Forum stwardnienie rozsiane SM